Towa Pharmaceutical Co., Ltd. (4553.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Towa Pharmaceutical Co., Ltd.
Address
2-11, Shinbashi-cho
Osaka, 571-8580
Japan
Phone
81 6 6900 9100
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4588
First IPO Date
April 05, 2004
Key Executives
| Name | Title | Pay | Year Born |
| Itsuro Yoshida | President & Representative Director | 113M | 1951 |
| Yasuyuki Oishi | Executive Officer | 0 | N/A |
| Takahiko Taniguchi | Senior Executive Officer & Head of Quality Assurance Division | 0 | N/A |
| Masaji Morikawa | Operating Officer & Division Manager of Sales and Marketing Division | 0 | N/A |
| Masao Tanaka | Director | 0 | 1954 |
| Osamu Uchikawa | Executive MD & Director | 0 | 1958 |
| Naomichi Hashizume | Human Resources Division Chief | 0 | N/A |
| Shigeki Fujita | Operating Officer & GM of Human Resource Development Center | 0 | N/A |
| Shiro Hatagami | Operating Officer and GM of Accounting & Finance Division | 0 | N/A |
| Tetsuo Yamashita | Operating Officer, Plant Manager of Okayama Plant & GM of Administration Department | 0 | N/A |
| Yutaka Okuda | Senior Operating Officer & Div Manager of R&D Div and Unit Manager of Innovative Tech Research | 0 | N/A |
| Takeshi Sugiura | Executive Officer | 0 | N/A |
Description
Towa Pharmaceutical Co., Ltd., along with its subsidiaries, is actively engaged in the entire pharmaceutical lifecycle within Japan, from researching and developing to manufacturing and marketing prescription medications, active pharmaceutical ingredients, and intermediate compounds. The company's extensive product offerings target critical therapeutic areas, including diabetes, digestive and nervous system disorders, and allergic conditions. Furthermore, their portfolio encompasses vitamins, antibiotics, and oncology treatments. With a comprehensive collection of approximately 700 distinct drug products, Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.
